Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laila Samiian

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The American Surgeon|April 2, 2004
Evaluation of gastrointestinal stromal tumors for recurrence rates and patterns of long-term follow-upLaila Samiian, Mitchell Weaver, Vic Velanovich
Clinical Breast Cancer|January 24, 2007
Resolution of hypoalbuminemia after excision of malignant phyllodes tumorLaila Samiian, Bruce Daniel, Irene Wapnir
Clinical Obstetrics and Gynecology|July 2, 2019
Breast Cancer and the Obstetrician-Gynecologist: A Focus on Screening, Risk Assessment and Treatment of Survivors With Genitourinary Syndrome of MenopauseBharti Jasra, Laila Samiian, Andrew M Kaunitz
The Journal of Surgical Research|October 4, 2018
Cost-effectiveness of surgeon performed intraoperative specimen ink in breast conservation surgeryAstrid Botty Van Den Bruele, Bharti Jasra, Carmen Smotherman, et al.
Clinical Advances in Hematology & Oncology : H&O|July 25, 2013
Efficacy of neoadjuvant cisplatin and oral capecitabine in triple-negative breast cancers: a pilot studyKhurram Tariq, Fauzia Rana, Laila Samiian, et al.
The American Surgeon|August 2, 2018
The Effect of Insurance and Race on Breast Cancer Tumor Biology and Short-Term OutcomesLaila Samiian, Priya Sharma, Astrid Botty Van Den Bruele, et al.
Journal of Geriatric Oncology|October 17, 2016
Impact of chemotherapy on medium-term physical function and activity of older breast cancer survivors, and associated biomarkersMartine Extermann, Christiaan Leeuwenburgh, Laila Samiian, et al.
The Lancet. Oncology|December 3, 2020
Addition of chemotherapy to local therapy in women aged 70 years or older with triple-negative breast cancer: a propensity-matched analysisJennifer A Crozier, Todd A Pezzi, Caitlin Hodge, et al.
Cancer Medicine|November 25, 2022
A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian and colorectal cancer susceptibility genesSukh Makhnoon, Brooke Levin, Megan Ensinger, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 14, 2024
Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registryCatherine Loveland-Jones, John Gaughan, Abigail Caudle, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The American Surgeon|April 2, 2004
Evaluation of gastrointestinal stromal tumors for recurrence rates and patterns of long-term follow-upLaila Samiian, Mitchell Weaver, Vic Velanovich
Clinical Breast Cancer|January 24, 2007
Resolution of hypoalbuminemia after excision of malignant phyllodes tumorLaila Samiian, Bruce Daniel, Irene Wapnir
Clinical Obstetrics and Gynecology|July 2, 2019
Breast Cancer and the Obstetrician-Gynecologist: A Focus on Screening, Risk Assessment and Treatment of Survivors With Genitourinary Syndrome of MenopauseBharti Jasra, Laila Samiian, Andrew M Kaunitz
The Journal of Surgical Research|October 4, 2018
Cost-effectiveness of surgeon performed intraoperative specimen ink in breast conservation surgeryAstrid Botty Van Den Bruele, Bharti Jasra, Carmen Smotherman, et al.
Clinical Advances in Hematology & Oncology : H&O|July 25, 2013
Efficacy of neoadjuvant cisplatin and oral capecitabine in triple-negative breast cancers: a pilot studyKhurram Tariq, Fauzia Rana, Laila Samiian, et al.
The American Surgeon|August 2, 2018
The Effect of Insurance and Race on Breast Cancer Tumor Biology and Short-Term OutcomesLaila Samiian, Priya Sharma, Astrid Botty Van Den Bruele, et al.
Journal of Geriatric Oncology|October 17, 2016
Impact of chemotherapy on medium-term physical function and activity of older breast cancer survivors, and associated biomarkersMartine Extermann, Christiaan Leeuwenburgh, Laila Samiian, et al.
The Lancet. Oncology|December 3, 2020
Addition of chemotherapy to local therapy in women aged 70 years or older with triple-negative breast cancer: a propensity-matched analysisJennifer A Crozier, Todd A Pezzi, Caitlin Hodge, et al.
Cancer Medicine|November 25, 2022
A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian and colorectal cancer susceptibility genesSukh Makhnoon, Brooke Levin, Megan Ensinger, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 14, 2024
Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registryCatherine Loveland-Jones, John Gaughan, Abigail Caudle, et al.
Pageof 2